Glucose Control as a Wound Healing Lever: Why Insulin Adherence Belongs in the Chart

Most diabetic foot ulcer chart notes describe the wound in detail — size, depth, exudate, tissue type — and mention glycemic control in a single line, if at all. That imbalance hides one of the strongest predictors of whether the wound will close.

The physiology, briefly

Hyperglycemia impairs healing through several parallel mechanisms:

• Neutrophil chemotaxis and phagocytosis drop when glucose is persistently >180 mg/dL
• Advanced glycation end-products stiffen collagen and reduce tensile strength of new tissue
• Microvascular perfusion narrows, worsening the ischemia already present in most DFU patients
• Peripheral neuropathy progresses, delaying the patient's own awareness of pressure or injury

Glucose variability — not just the average — matters. A patient with an A1c of 7.5 who swings between 60 and 300 heals worse than a steady 8.0.

What belongs in the wound chart

A DFU note that captures healing potential should include, alongside the wound assessment:

Glycemic snapshot

• Most recent A1c and date
• Fasting or point-of-care glucose at the visit
• Time-in-range if CGM data is available
• Any episodes of hypoglycemia since last visit

Insulin regimen and adherence

• Current regimen (basal, bolus, mixed, pump)
• Missed doses since last visit — and the reason
• Injection site condition (lipohypertrophy on exam)
• Storage and technique concerns noted by the patient

Interventions

• Education delivered (site rotation, storage, syringe vs pen, 10-second hold)
• Referrals: endocrinology, diabetes educator, pharmacy
• Adjustments coordinated with the prescribing clinician

Why this shows up in the healing trajectory

When glucose and adherence data live in the same record as wound area, the healing analytics dashboard can flag stalled trajectories that correlate with glycemic drift rather than local wound factors — the difference between escalating to advanced therapy and fixing the underlying driver first. Predictive curves built from visit data (see Inside the healing trajectory) are only as useful as the covariates you capture.

Making it fit the visit

Capturing this without adding minutes to the encounter is where an AI scribe for wound care matters — glycemic history, insulin adherence, and patient-reported barriers can be pulled into the note from the conversation rather than typed after hours. Patient-facing reinforcement is handled through patient engagement and education, so the education documented in the chart is the same education the patient actually receives between visits.

The takeaway

Insulin adherence is a wound care metric. Treating it as an endocrinology problem that lives in a different chart is one reason DFU healing rates lag. Documenting it alongside wound measurements — every visit — is the change that moves the trajectory.